Global Typhoid Fever Vaccines Market Insights and Forecast to 2028

Q: Who are the key players in the typhoid fever vaccines market?

Some of the key players are Segment, Sanofi Pasteur, GlaxoSmithKline PLC, Bharat Biotech, PaxVax, Biomed, Prokarium, China National Biotec Group, Company, Japan, Others.

Code: QYRE-Auto-23J780

Report

February 2022

Pages:93

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

China National Biotec Group

Company

Japan

Segment

Typhoid fever is contracted by drinking or eating the Salmonella bacteria in contaminated food or water. Typhoid Fever Vaccines prevent typhoid fever and provide protection against it.

Market Analysis and Insights: Global Typhoid Fever Vaccines Market

Due to the COVID-19 pandemic, the global Typhoid Fever Vaccines market size is estimated to be worth US$ 233.1 million in 2022 and is forecast to a readjusted size of US$ 344 million by 2028 with a CAGR of 6.7% during the review period.

Fully considering the economic change by this health crisis, Live Attenuated Vaccine accounting for % of the Typhoid Fever Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Government Institution segment is altered to an % CAGR throughout this forecast period.

China Typhoid Fever Vaccines market size is valued at US$ million in 2021, while the US and Europe Typhoid Fever Vaccines are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Typhoid Fever Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Typhoid Fever Vaccines include Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, PaxVax, Biomed, Prokarium and China National Biotec Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Typhoid Fever Vaccines Scope and Segment

Typhoid Fever Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Typhoid Fever Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Live Attenuated Vaccine

Conjugate Vaccine

Capsular Polysaccharide Vaccines

Others

Segment by Application

Government Institution

Private Sector

BY COMPANY

Sanofi Pasteur

GlaxoSmithKline

Bharat Biotech

PaxVax

Biomed

Prokarium

China National Biotec Group

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

China National Biotec Group

Company

Japan

Segment

1 Study Coverage

1.1 Typhoid Fever Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global Typhoid Fever Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Live Attenuated Vaccine

1.2.3 Conjugate Vaccine

1.2.4 Capsular Polysaccharide Vaccines

1.2.5 Others

1.3 Market by Application

1.3.1 Global Typhoid Fever Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Government Institution

1.3.3 Private Sector

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Typhoid Fever Vaccines Sales Estimates and Forecasts 2017-2028

2.2 Global Typhoid Fever Vaccines Revenue Estimates and Forecasts 2017-2028

2.3 Global Typhoid Fever Vaccines Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Typhoid Fever Vaccines Sales by Region

2.4.1 Global Typhoid Fever Vaccines Sales by Region (2017-2022)

2.4.2 Global Sales Typhoid Fever Vaccines by Region (2023-2028)

2.5 Global Typhoid Fever Vaccines Revenue by Region

2.5.1 Global Typhoid Fever Vaccines Revenue by Region (2017-2022)

2.5.2 Global Typhoid Fever Vaccines Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Typhoid Fever Vaccines Sales by Manufacturers

3.1.1 Global Top Typhoid Fever Vaccines Manufacturers by Sales (2017-2022)

3.1.2 Global Typhoid Fever Vaccines Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Typhoid Fever Vaccines in 2021

3.2 Global Typhoid Fever Vaccines Revenue by Manufacturers

3.2.1 Global Typhoid Fever Vaccines Revenue by Manufacturers (2017-2022)

3.2.2 Global Typhoid Fever Vaccines Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Typhoid Fever Vaccines Revenue in 2021

3.3 Global Typhoid Fever Vaccines Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Typhoid Fever Vaccines Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Typhoid Fever Vaccines Sales by Type

4.1.1 Global Typhoid Fever Vaccines Historical Sales by Type (2017-2022)

4.1.2 Global Typhoid Fever Vaccines Forecasted Sales by Type (2023-2028)

4.1.3 Global Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)

4.2 Global Typhoid Fever Vaccines Revenue by Type

4.2.1 Global Typhoid Fever Vaccines Historical Revenue by Type (2017-2022)

4.2.2 Global Typhoid Fever Vaccines Forecasted Revenue by Type (2023-2028)

4.2.3 Global Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)

4.3 Global Typhoid Fever Vaccines Price by Type

4.3.1 Global Typhoid Fever Vaccines Price by Type (2017-2022)

4.3.2 Global Typhoid Fever Vaccines Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Typhoid Fever Vaccines Sales by Application

5.1.1 Global Typhoid Fever Vaccines Historical Sales by Application (2017-2022)

5.1.2 Global Typhoid Fever Vaccines Forecasted Sales by Application (2023-2028)

5.1.3 Global Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)

5.2 Global Typhoid Fever Vaccines Revenue by Application

5.2.1 Global Typhoid Fever Vaccines Historical Revenue by Application (2017-2022)

5.2.2 Global Typhoid Fever Vaccines Forecasted Revenue by Application (2023-2028)

5.2.3 Global Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)

5.3 Global Typhoid Fever Vaccines Price by Application

5.3.1 Global Typhoid Fever Vaccines Price by Application (2017-2022)

5.3.2 Global Typhoid Fever Vaccines Price Forecast by Application (2023-2028)

6 North America

6.1 North America Typhoid Fever Vaccines Market Size by Type

6.1.1 North America Typhoid Fever Vaccines Sales by Type (2017-2028)

6.1.2 North America Typhoid Fever Vaccines Revenue by Type (2017-2028)

6.2 North America Typhoid Fever Vaccines Market Size by Application

6.2.1 North America Typhoid Fever Vaccines Sales by Application (2017-2028)

6.2.2 North America Typhoid Fever Vaccines Revenue by Application (2017-2028)

6.3 North America Typhoid Fever Vaccines Market Size by Country

6.3.1 North America Typhoid Fever Vaccines Sales by Country (2017-2028)

6.3.2 North America Typhoid Fever Vaccines Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Typhoid Fever Vaccines Market Size by Type

7.1.1 Europe Typhoid Fever Vaccines Sales by Type (2017-2028)

7.1.2 Europe Typhoid Fever Vaccines Revenue by Type (2017-2028)

7.2 Europe Typhoid Fever Vaccines Market Size by Application

7.2.1 Europe Typhoid Fever Vaccines Sales by Application (2017-2028)

7.2.2 Europe Typhoid Fever Vaccines Revenue by Application (2017-2028)

7.3 Europe Typhoid Fever Vaccines Market Size by Country

7.3.1 Europe Typhoid Fever Vaccines Sales by Country (2017-2028)

7.3.2 Europe Typhoid Fever Vaccines Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Typhoid Fever Vaccines Market Size by Type

8.1.1 Asia Pacific Typhoid Fever Vaccines Sales by Type (2017-2028)

8.1.2 Asia Pacific Typhoid Fever Vaccines Revenue by Type (2017-2028)

8.2 Asia Pacific Typhoid Fever Vaccines Market Size by Application

8.2.1 Asia Pacific Typhoid Fever Vaccines Sales by Application (2017-2028)

8.2.2 Asia Pacific Typhoid Fever Vaccines Revenue by Application (2017-2028)

8.3 Asia Pacific Typhoid Fever Vaccines Market Size by Region

8.3.1 Asia Pacific Typhoid Fever Vaccines Sales by Region (2017-2028)

8.3.2 Asia Pacific Typhoid Fever Vaccines Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Typhoid Fever Vaccines Market Size by Type

9.1.1 Latin America Typhoid Fever Vaccines Sales by Type (2017-2028)

9.1.2 Latin America Typhoid Fever Vaccines Revenue by Type (2017-2028)

9.2 Latin America Typhoid Fever Vaccines Market Size by Application

9.2.1 Latin America Typhoid Fever Vaccines Sales by Application (2017-2028)

9.2.2 Latin America Typhoid Fever Vaccines Revenue by Application (2017-2028)

9.3 Latin America Typhoid Fever Vaccines Market Size by Country

9.3.1 Latin America Typhoid Fever Vaccines Sales by Country (2017-2028)

9.3.2 Latin America Typhoid Fever Vaccines Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Typhoid Fever Vaccines Market Size by Type

10.1.1 Middle East and Africa Typhoid Fever Vaccines Sales by Type (2017-2028)

10.1.2 Middle East and Africa Typhoid Fever Vaccines Revenue by Type (2017-2028)

10.2 Middle East and Africa Typhoid Fever Vaccines Market Size by Application

10.2.1 Middle East and Africa Typhoid Fever Vaccines Sales by Application (2017-2028)

10.2.2 Middle East and Africa Typhoid Fever Vaccines Revenue by Application (2017-2028)

10.3 Middle East and Africa Typhoid Fever Vaccines Market Size by Country

10.3.1 Middle East and Africa Typhoid Fever Vaccines Sales by Country (2017-2028)

10.3.2 Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Sanofi Pasteur

11.1.1 Sanofi Pasteur Corporation Information

11.1.2 Sanofi Pasteur Overview

11.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Sanofi Pasteur Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sanofi Pasteur Recent Developments

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Corporation Information

11.2.2 GlaxoSmithKline Overview

11.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 GlaxoSmithKline Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GlaxoSmithKline Recent Developments

11.3 Bharat Biotech

11.3.1 Bharat Biotech Corporation Information

11.3.2 Bharat Biotech Overview

11.3.3 Bharat Biotech Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Bharat Biotech Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Bharat Biotech Recent Developments

11.4 PaxVax

11.4.1 PaxVax Corporation Information

11.4.2 PaxVax Overview

11.4.3 PaxVax Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 PaxVax Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 PaxVax Recent Developments

11.5 Biomed

11.5.1 Biomed Corporation Information

11.5.2 Biomed Overview

11.5.3 Biomed Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Biomed Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Biomed Recent Developments

11.6 Prokarium

11.6.1 Prokarium Corporation Information

11.6.2 Prokarium Overview

11.6.3 Prokarium Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Prokarium Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Prokarium Recent Developments

11.7 China National Biotec Group

11.7.1 China National Biotec Group Corporation Information

11.7.2 China National Biotec Group Overview

11.7.3 China National Biotec Group Typhoid Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 China National Biotec Group Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 China National Biotec Group Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Typhoid Fever Vaccines Industry Chain Analysis

12.2 Typhoid Fever Vaccines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Typhoid Fever Vaccines Production Mode & Process

12.4 Typhoid Fever Vaccines Sales and Marketing

12.4.1 Typhoid Fever Vaccines Sales Channels

12.4.2 Typhoid Fever Vaccines Distributors

12.5 Typhoid Fever Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Typhoid Fever Vaccines Industry Trends

13.2 Typhoid Fever Vaccines Market Drivers

13.3 Typhoid Fever Vaccines Market Challenges

13.4 Typhoid Fever Vaccines Market Restraints

14 Key Findings in The Global Typhoid Fever Vaccines Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

China National Biotec Group

Company

Japan

Segment

List of Tables

Table 1. Global Typhoid Fever Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Live Attenuated Vaccine

Table 3. Major Manufacturers of Conjugate Vaccine

Table 4. Major Manufacturers of Capsular Polysaccharide Vaccines

Table 5. Major Manufacturers of Others

Table 6. Global Typhoid Fever Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Typhoid Fever Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 8. Global Typhoid Fever Vaccines Sales by Region (2017-2022) & (K Doses)

Table 9. Global Typhoid Fever Vaccines Sales Market Share by Region (2017-2022)

Table 10. Global Typhoid Fever Vaccines Sales by Region (2023-2028) & (K Doses)

Table 11. Global Typhoid Fever Vaccines Sales Market Share by Region (2023-2028)

Table 12. Global Typhoid Fever Vaccines Revenue by Region (2017-2022) & (US$ Million)

Table 13. Global Typhoid Fever Vaccines Revenue Market Share by Region (2017-2022)

Table 14. Global Typhoid Fever Vaccines Revenue by Region (2023-2028) & (US$ Million)

Table 15. Global Typhoid Fever Vaccines Revenue Market Share by Region (2023-2028)

Table 16. Global Typhoid Fever Vaccines Sales by Manufacturers (2017-2022) & (K Doses)

Table 17. Global Typhoid Fever Vaccines Sales Share by Manufacturers (2017-2022)

Table 18. Global Typhoid Fever Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 19. Global Typhoid Fever Vaccines Revenue Share by Manufacturers (2017-2022)

Table 20. Typhoid Fever Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)

Table 21. Global Typhoid Fever Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Typhoid Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Typhoid Fever Vaccines as of 2021)

Table 23. Typhoid Fever Vaccines Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Typhoid Fever Vaccines Product Offered

Table 25. Date of Manufacturers Enter into Typhoid Fever Vaccines Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 28. Global Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)

Table 29. Global Typhoid Fever Vaccines Sales Share by Type (2017-2022)

Table 30. Global Typhoid Fever Vaccines Sales Share by Type (2023-2028)

Table 31. Global Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 32. Global Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 33. Global Typhoid Fever Vaccines Revenue Share by Type (2017-2022)

Table 34. Global Typhoid Fever Vaccines Revenue Share by Type (2023-2028)

Table 35. Typhoid Fever Vaccines Price by Type (2017-2022) & (USD/Dose)

Table 36. Global Typhoid Fever Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)

Table 37. Global Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 38. Global Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)

Table 39. Global Typhoid Fever Vaccines Sales Share by Application (2017-2022)

Table 40. Global Typhoid Fever Vaccines Sales Share by Application (2023-2028)

Table 41. Global Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 42. Global Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 43. Global Typhoid Fever Vaccines Revenue Share by Application (2017-2022)

Table 44. Global Typhoid Fever Vaccines Revenue Share by Application (2023-2028)

Table 45. Typhoid Fever Vaccines Price by Application (2017-2022) & (USD/Dose)

Table 46. Global Typhoid Fever Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)

Table 47. North America Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 48. North America Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)

Table 49. North America Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 50. North America Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 51. North America Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 52. North America Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)

Table 53. North America Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 54. North America Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 55. North America Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)

Table 56. North America Typhoid Fever Vaccines Sales by Country (2023-2028) & (K Doses)

Table 57. North America Typhoid Fever Vaccines Revenue by Country (2017-2022) & (US$ Million)

Table 58. North America Typhoid Fever Vaccines Revenue by Country (2023-2028) & (US$ Million)

Table 59. Europe Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 60. Europe Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)

Table 61. Europe Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 62. Europe Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 63. Europe Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 64. Europe Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)

Table 65. Europe Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 66. Europe Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 67. Europe Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)

Table 68. Europe Typhoid Fever Vaccines Sales by Country (2023-2028) & (K Doses)

Table 69. Europe Typhoid Fever Vaccines Revenue by Country (2017-2022) & (US$ Million)

Table 70. Europe Typhoid Fever Vaccines Revenue by Country (2023-2028) & (US$ Million)

Table 71. Asia Pacific Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 72. Asia Pacific Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)

Table 73. Asia Pacific Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 74. Asia Pacific Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 75. Asia Pacific Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 76. Asia Pacific Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)

Table 77. Asia Pacific Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 78. Asia Pacific Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 79. Asia Pacific Typhoid Fever Vaccines Sales by Region (2017-2022) & (K Doses)

Table 80. Asia Pacific Typhoid Fever Vaccines Sales by Region (2023-2028) & (K Doses)

Table 81. Asia Pacific Typhoid Fever Vaccines Revenue by Region (2017-2022) & (US$ Million)

Table 82. Asia Pacific Typhoid Fever Vaccines Revenue by Region (2023-2028) & (US$ Million)

Table 83. Latin America Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 84. Latin America Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)

Table 85. Latin America Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 86. Latin America Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 87. Latin America Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 88. Latin America Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)

Table 89. Latin America Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 90. Latin America Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 91. Latin America Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)

Table 92. Latin America Typhoid Fever Vaccines Sales by Country (2023-2028) & (K Doses)

Table 93. Latin America Typhoid Fever Vaccines Revenue by Country (2017-2022) & (US$ Million)

Table 94. Latin America Typhoid Fever Vaccines Revenue by Country (2023-2028) & (US$ Million)

Table 95. Middle East and Africa Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 96. Middle East and Africa Typhoid Fever Vaccines Sales by Type (2023-2028) & (K Doses)

Table 97. Middle East and Africa Typhoid Fever Vaccines Revenue by Type (2017-2022) & (US$ Million)

Table 98. Middle East and Africa Typhoid Fever Vaccines Revenue by Type (2023-2028) & (US$ Million)

Table 99. Middle East and Africa Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 100. Middle East and Africa Typhoid Fever Vaccines Sales by Application (2023-2028) & (K Doses)

Table 101. Middle East and Africa Typhoid Fever Vaccines Revenue by Application (2017-2022) & (US$ Million)

Table 102. Middle East and Africa Typhoid Fever Vaccines Revenue by Application (2023-2028) & (US$ Million)

Table 103. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)

Table 104. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2023-2028) & (K Doses)

Table 105. Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2017-2022) & (US$ Million)

Table 106. Middle East and Africa Typhoid Fever Vaccines Revenue by Country (2023-2028) & (US$ Million)

Table 107. Sanofi Pasteur Corporation Information

Table 108. Sanofi Pasteur Description and Major Businesses

Table 109. Sanofi Pasteur Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 110. Sanofi Pasteur Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Sanofi Pasteur Recent Developments

Table 112. GlaxoSmithKline Corporation Information

Table 113. GlaxoSmithKline Description and Major Businesses

Table 114. GlaxoSmithKline Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 115. GlaxoSmithKline Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. GlaxoSmithKline Recent Developments

Table 117. Bharat Biotech Corporation Information

Table 118. Bharat Biotech Description and Major Businesses

Table 119. Bharat Biotech Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 120. Bharat Biotech Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Bharat Biotech Recent Developments

Table 122. PaxVax Corporation Information

Table 123. PaxVax Description and Major Businesses

Table 124. PaxVax Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 125. PaxVax Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. PaxVax Recent Developments

Table 127. Biomed Corporation Information

Table 128. Biomed Description and Major Businesses

Table 129. Biomed Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 130. Biomed Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Biomed Recent Developments

Table 132. Prokarium Corporation Information

Table 133. Prokarium Description and Major Businesses

Table 134. Prokarium Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 135. Prokarium Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Prokarium Recent Developments

Table 137. China National Biotec Group Corporation Information

Table 138. China National Biotec Group Description and Major Businesses

Table 139. China National Biotec Group Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)

Table 140. China National Biotec Group Typhoid Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. China National Biotec Group Recent Developments

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Typhoid Fever Vaccines Distributors List

Table 145. Typhoid Fever Vaccines Customers List

Table 146. Typhoid Fever Vaccines Market Trends

Table 147. Typhoid Fever Vaccines Market Drivers

Table 148. Typhoid Fever Vaccines Market Challenges

Table 149. Typhoid Fever Vaccines Market Restraints

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

List of Figures

Figure 1. Typhoid Fever Vaccines Product Picture

Figure 3. Global Typhoid Fever Vaccines Market Share by Type in 2021 & 2028

Figure 3. Live Attenuated Vaccine Product Picture

Figure 4. Conjugate Vaccine Product Picture

Figure 5. Capsular Polysaccharide Vaccines Product Picture

Figure 6. Others Product Picture

Figure 7. Global Typhoid Fever Vaccines Market Share by Application in 2021 & 2028

Figure 8. Government Institution

Figure 9. Private Sector

Figure 10. Typhoid Fever Vaccines Report Years Considered

Figure 11. Global Typhoid Fever Vaccines Sales 2017-2028 (K Doses)

Figure 12. Global Typhoid Fever Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Typhoid Fever Vaccines Revenue 2017-2028 (US$ Million)

Figure 14. Global Typhoid Fever Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 15. Global Typhoid Fever Vaccines Sales Market Share by Region (2017-2022)

Figure 16. Global Typhoid Fever Vaccines Sales Market Share by Region (2023-2028)

Figure 17. North America Typhoid Fever Vaccines Sales YoY (2017-2028) & (K Doses)

Figure 18. North America Typhoid Fever Vaccines Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Europe Typhoid Fever Vaccines Sales YoY (2017-2028) & (K Doses)

Figure 20. Europe Typhoid Fever Vaccines Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Asia-Pacific Typhoid Fever Vaccines Sales YoY (2017-2028) & (K Doses)

Figure 22. Asia-Pacific Typhoid Fever Vaccines Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Latin America Typhoid Fever Vaccines Sales YoY (2017-2028) & (K Doses)

Figure 24. Latin America Typhoid Fever Vaccines Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Middle East & Africa Typhoid Fever Vaccines Sales YoY (2017-2028) & (K Doses)

Figure 26. Middle East & Africa Typhoid Fever Vaccines Revenue YoY (2017-2028) & (US$ Million)

Figure 27. The Typhoid Fever Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 28. The Top 5 and 10 Largest Manufacturers of Typhoid Fever Vaccines in the World: Market Share by Typhoid Fever Vaccines Revenue in 2021

Figure 29. Global Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 30. Global Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)

Figure 31. Global Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)

Figure 32. Global Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)

Figure 33. Global Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)

Figure 34. North America Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)

Figure 35. North America Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)

Figure 36. North America Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)

Figure 37. North America Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)

Figure 38. North America Typhoid Fever Vaccines Sales Share by Country (2017-2028)

Figure 39. North America Typhoid Fever Vaccines Revenue Share by Country (2017-2028)

Figure 40. U.S. Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 41. Canada Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 42. Europe Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)

Figure 43. Europe Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)

Figure 44. Europe Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)

Figure 45. Europe Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)

Figure 46. Europe Typhoid Fever Vaccines Sales Share by Country (2017-2028)

Figure 47. Europe Typhoid Fever Vaccines Revenue Share by Country (2017-2028)

Figure 48. Germany Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 49. France Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 50. U.K. Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 51. Italy Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 52. Russia Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 53. Asia Pacific Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)

Figure 54. Asia Pacific Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)

Figure 55. Asia Pacific Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)

Figure 56. Asia Pacific Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)

Figure 57. Asia Pacific Typhoid Fever Vaccines Sales Share by Region (2017-2028)

Figure 58. Asia Pacific Typhoid Fever Vaccines Revenue Share by Region (2017-2028)

Figure 59. China Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 60. Japan Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 61. South Korea Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 62. India Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 63. Australia Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 64. Taiwan Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 65. Indonesia Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 66. Thailand Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 67. Malaysia Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 68. Philippines Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 69. Latin America Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)

Figure 70. Latin America Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)

Figure 71. Latin America Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)

Figure 72. Latin America Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)

Figure 73. Latin America Typhoid Fever Vaccines Sales Share by Country (2017-2028)

Figure 74. Latin America Typhoid Fever Vaccines Revenue Share by Country (2017-2028)

Figure 75. Mexico Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 76. Brazil Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 77. Argentina Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 78. Middle East and Africa Typhoid Fever Vaccines Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Typhoid Fever Vaccines Revenue Market Share by Type (2017-2028)

Figure 80. Middle East and Africa Typhoid Fever Vaccines Sales Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Typhoid Fever Vaccines Revenue Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Typhoid Fever Vaccines Sales Share by Country (2017-2028)

Figure 83. Middle East and Africa Typhoid Fever Vaccines Revenue Share by Country (2017-2028)

Figure 84. Turkey Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 85. Saudi Arabia Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 86. U.A.E Typhoid Fever Vaccines Revenue (2017-2028) & (US$ Million)

Figure 87. Typhoid Fever Vaccines Value Chain

Figure 88. Typhoid Fever Vaccines Production Process

Figure 89. Channels of Distribution

Figure 90. Distributors Profiles

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Typhoid Fever Vaccines Market Insights and Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-23J780

Global Typhoid Fever Vaccines Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26K6048

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-20L6129

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-4F6384

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-16N6009

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions